Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 4
2008 3
2009 2
2011 1
2012 2
2013 1
2014 4
2015 9
2016 7
2017 10
2018 7
2019 3
2020 6
2021 9
2022 22
2023 25
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Update of EULAR recommendations for the treatment of systemic sclerosis.
Kowal-Bielecka O, Fransen J, Avouac J, Becker M, Kulak A, Allanore Y, Distler O, Clements P, Cutolo M, Czirjak L, Damjanov N, Del Galdo F, Denton CP, Distler JHW, Foeldvari I, Figelstone K, Frerix M, Furst DE, Guiducci S, Hunzelmann N, Khanna D, Matucci-Cerinic M, Herrick AL, van den Hoogen F, van Laar JM, Riemekasten G, Silver R, Smith V, Sulli A, Tarner I, Tyndall A, Welling J, Wigley F, Valentini G, Walker UA, Zulian F, Müller-Ladner U; EUSTAR Coauthors. Kowal-Bielecka O, et al. Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9. Ann Rheum Dis. 2017. PMID: 27941129 Free article.
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways.
López-Isac E, Acosta-Herrera M, Kerick M, Assassi S, Satpathy AT, Granja J, Mumbach MR, Beretta L, Simeón CP, Carreira P, Ortego-Centeno N, Castellvi I, Bossini-Castillo L, Carmona FD, Orozco G, Hunzelmann N, Distler JHW, Franke A, Lunardi C, Moroncini G, Gabrielli A, de Vries-Bouwstra J, Wijmenga C, Koeleman BPC, Nordin A, Padyukov L, Hoffmann-Vold AM, Lie B; European Scleroderma Group†; Proudman S, Stevens W, Nikpour M; Australian Scleroderma Interest Group (ASIG); Vyse T, Herrick AL, Worthington J, Denton CP, Allanore Y, Brown MA, Radstake TRDJ, Fonseca C, Chang HY, Mayes MD, Martin J. López-Isac E, et al. Among authors: moroncini g. Nat Commun. 2019 Oct 31;10(1):4955. doi: 10.1038/s41467-019-12760-y. Nat Commun. 2019. PMID: 31672989 Free PMC article.
Reply.
Luchetti MM, Moroncini G, Svegliati S, Larcher F, Avvedimento EV, Gabrielli A. Luchetti MM, et al. Among authors: moroncini g. Arthritis Rheumatol. 2017 Aug;69(8):1703-1704. doi: 10.1002/art.40138. Epub 2017 Jun 14. Arthritis Rheumatol. 2017. PMID: 28464528 No abstract available.
Biologics in Inflammatory Immune-mediated Systemic Diseases.
Moroncini G, Calogera G, Benfaremo D, Gabrielli A. Moroncini G, et al. Curr Pharm Biotechnol. 2017;18(12):1008-1016. doi: 10.2174/1389201019666171226152448. Curr Pharm Biotechnol. 2017. PMID: 29278213 Review.
Agonistic antibodies in systemic sclerosis.
Moroncini G, Svegliati Baroni S, Gabrielli A. Moroncini G, et al. Immunol Lett. 2018 Mar;195:83-87. doi: 10.1016/j.imlet.2017.10.007. Epub 2017 Oct 13. Immunol Lett. 2018. PMID: 29032187 Review.
Putative functional pathogenic autoantibodies in systemic sclerosis.
Benfaremo D, Svegliati Baroni S, Manfredi L, Moroncini G, Gabrielli A. Benfaremo D, et al. Among authors: moroncini g. Eur J Rheumatol. 2020 Oct;7(Suppl 3):S181-S186. doi: 10.5152/eurjrheum.2020.19131. Epub 2020 Oct 1. Eur J Rheumatol. 2020. PMID: 33164733 Free PMC article. Review.
Role of Endothelium in Cardiovascular Sequelae of Long COVID.
Santoro L, Zaccone V, Falsetti L, Ruggieri V, Danese M, Miro C, Di Giorgio A, Nesci A, D'Alessandro A, Moroncini G, Santoliquido A. Santoro L, et al. Among authors: moroncini g. Biomedicines. 2023 Aug 9;11(8):2239. doi: 10.3390/biomedicines11082239. Biomedicines. 2023. PMID: 37626735 Free PMC article. Review.
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis.
Paolini C, Agarbati S, Benfaremo D, Mozzicafreddo M, Svegliati S, Moroncini G. Paolini C, et al. Among authors: moroncini g. Int J Mol Sci. 2022 Mar 31;23(7):3904. doi: 10.3390/ijms23073904. Int J Mol Sci. 2022. PMID: 35409263 Free PMC article. Review.
113 results